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A continuum of admixture in the Western
Hemisphere revealed by the African Diaspora genome
Rasika Ann Mathias1,2, Margaret A. Taub3, Christopher R. Gignoux 4,*, Wenqing Fu5,*, Shaila Musharoff4,*,
Timothy D. O’Connor6,7,8,*, Candelaria Vergara1, Dara G. Torgerson9, Maria Pino-Yanes9,10, Suyash S. Shringarpure4,
Lili Huang1, Nicholas Rafaels1, Meher Preethi Boorgula1, Henry Richard Johnston11, Victor E. Ortega12, Albert M. Levin13,
Wei Song6,7,8, Raul Torres14, Badri Padhukasahasram15, Celeste Eng9, Delmy-Aracely Mejia-Mejia16,17, Trevor Ferguson18,
Zhaohui S. Qin11, Alan F. Scott1, Maria Yazdanbakhsh19, James G. Wilson20, Javier Marrugo21, Leslie A. Lange22, Rajesh
Kumar23,24, Pedro C. Avila25, L. Keoki Williams15,26, Harold Watson27,28, Lorraine B. Ware29,30, Christopher Olopade31,
Olufunmilayo Olopade32, Ricardo Oliveira33, Carole Ober34, Dan L. Nicolae32,35, Deborah Meyers12, Alvaro Mayorga16,
Jennifer Knight-Madden18, Tina Hartert29, Nadia N. Hansel1, Marilyn G. Foreman36, Jean G. Ford2,37, Mezbah U. Faruque38,
Georgia M. Dunston38,39, Luis Caraballo40, Esteban G. Burchard9,41, Eugene Bleecker12, Maria Ilma Araujo42, Edwin
Francisco Herrera-Paz16,17,43, Kimberly Gietzen44, Wendy E. Grus45, Michael Bamshad46, Carlos D. Bustamante4, Eimear E.
Kenny4,47, Ryan D. Hernandez41,48,49, Terri H. Beaty2, Ingo Ruczinski3, Joshua Akey5, CAAPAw & Kathleen C. Barnes1,2
The African Diaspora in the Western Hemisphere represents one of the largest forced migrations in
history and had a profound impact on genetic diversity in modern populations. To date, the fine-scale
population structure of descendants of the African Diaspora remains largely uncharacterized. Here we
present genetic variation from deeply sequenced genomes of 642 individuals from North and South
American, Caribbean and West African populations, substantially increasing the lexicon of human
genomic variation and suggesting much variation remains to be discovered in African-admixed popu-
lations in the Americas. We summarize genetic variation in these populations, quantifying the post-
colonial sex-biased European gene flow across multiple regions. Moreover, we refine estimates on the
burden of deleterious variants carried across populations and how this varies with African ancestry. Our
data are an important resource for empowering disease mapping studies in African-admixed individuals
and will facilitate gene discovery for diseases disproportionately affecting individuals of African ancestry.
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A
disproportionate burden of morbidity, disability and
death from common, chronic diseases associated with
modern lifestyles persists among US racial and ethnic
minority populations, most notably among individuals of African
ancestry1. Unfortunately, the complexity of colonial history has
been highly understudied and homogenized: African Americans
and admixed populations in Latin America and the Caribbean are
grouped into a single racial construct by the American census,
which then is often applied in studies of health disparities. This
fails to capture the distribution of genetic variation among these
populations2. In medical genetics, this is especially problematic,
where studies of populations of African descent in the Americas
do not adequately account for fine-scale population structure
resulting from the components of continental ancestry, in
particular the lower linkage disequilibrium and decreased
genome-wide array coverage in these populations. Although the
Americas have been a source of large genome-wide association
studies, populations of African descent continue to be
understudied.
To address issues of genome-wide genetic diversity, ancestry
and admixture, and limitations in commercial genome-wide
association studies array coverage in populations of African
descent in the Americas (representing the African Diaspora), we
performed the largest whole-genome sequencing (WGS) study to
date on populations with African ancestry in the Americas. We
sequenced 642 unrelated individuals who self-reported African
ancestry from 15 North, Central, and South American and
Caribbean populations plus Yoruba-speaking individuals from
Ibadan, Nigeria, as part of the Consortium on Asthma among
African-ancestry Populations in the Americas (CAAPA3). These
data substantially increase the lexicon of known human genomic
variation and suggest an abundance of variation remains to be
discovered with more studies of African-admixed populations in
the Americas. We summarize genetic variation resulting from the
African Diaspora across the Americas and into the Caribbean,
quantifying the post-colonial sex-biased European gene flow
across multiple regions. Moreover, leveraging our high-coverage
whole-genome data we are able to refine estimates on the burden
of deleterious variants carried across populations and how this
varies with African ancestry. Our data will serve as an important
resource for empowering disease mapping studies in African-
admixed individuals and facilitate gene discovery for diseases
disproportionately affecting individuals of African ancestry.
Results
Study design overview. The geographic locations of the 15 North,
Central, and South American and Caribbean populations
sequenced for this study are illustrated in Fig. 1a and detailed
information on each of the 15 individual component populations
is described in detail in Supplementary Note 1. Supplementary
Notes 2–9, Supplementary Figs 1–3 and Supplementary Tables 1
and 2 contain detailed information on sequencing and quality-
control pipelines, asthma status, ancestry, observed genetic
variation, sequencing depth and call rates by sampling
site/ethnicity. Although designed as a case–control study for
asthma and associated phenotypes, the systematic characteriza-
tion of ancestry in all individuals has merit on its own. Asthma is
a disease of moderate heritability4,5, yet few loci have been
discovered in populations of African descent (note as exceptions
refs 6,7), and contrasting the study sites yields large sociocultural
and environmental heterogeneity that could affect asthma risk.
Therefore, across the entire genome, patterns of variation will
tend to receive little confounding from our case–control design.
Characterization of novel variation. Among these deeply
sequenced samples, we observed 43.2 million bi-allelic autosomal
single-nucleotide variants (SNVs, described in Supplementary
Tables 3–7), a greater number than reported from low-coverage
sequencing of 1,092 worldwide samples (38 million, from the
1000 Genomes Project (TGP)8). A large fraction of these SNVs
(N¼ 20.7 million) were unique to CAAPA. Of the 43.2 million
total SNVs, 16.3 million (38%) were singletons (that is, observed
in only a single individual), 12.4 million (29%) were observed in
41 individual but at a minor allele frequency (MAF) o1%, 6.5
million (24%) had 1%rMAFr5% and only 7.8 million (29%) of
all SNVs were common (MAF45%), consistent with previous
reports9–11. Deep sequencing within CAAPA reveals new
variants across all categories of MAF (Fig. 1b,c), with a
significant excess rate of novel variant discovery on African
segments of the genome (Fig. 1d). There were 13.8 million novel
singleton variants, 5.3 million novel variants observed in 41
individual but at a MAFo1%, 429,721 had 1%rMAFr5% and
only 117,367 novel SNVs were common (MAF45%). Rarefaction
curves for various classes of alleles (see Methods and
Supplementary Fig. 4) and jackknife projections12 suggest if our
sample size were doubled, we would discover 68% more
apparently damaging coding SNVs (defined by PolyPhen2, see
Methods) and 57% more deleterious SNVs genome wide (defined
by PhyloPNH score, see Methods). Importantly, with larger
sample sizes, we expect to discover deleterious variants at a higher
rate than selectively neutral variants, as the former should have
lower average MAFs.
Variation captures population structure and history. The
CAAPA resource represents diverse groups with varying levels of
African contributions to ancestry. Relying on three reference
ancestral populations13 and an optimal K¼ 3 (see Methods and
Supplementary Fig. 5) global admixture analysis reveals
individual autosomal genome-wide estimates of African
ancestry ranged from 4% to 499% in CAAPA. The mean
African ancestry varied widely among populations from 27%
among Puerto Ricans to 89% among Jamaicans in CAAPA
groups and approaching 100% as expected among Nigerians
(Fig. 2a and see Methods). Principal component analysis (PCA;
Fig. 2b and Supplementary Figs 6 and 7) reveals a cluster
comprising African American, Barbadian, Jamaican and Nigerian
samples along a gradient between European and African ancestral
groups, whereas samples from the Dominican Republic,
Honduras, Colombia, Puerto Rico and Brazil show more three-
way admixture with an average Native American ancestry of 9%,
17%, 28%, 12% and 10%, respectively (Supplementary Table 1).
We found minimal differences between all African American
populations sampled (Supplementary Fig. 6), consistent with a
shared history of many African Americans in the United States14.
A third component distinguishes the Honduran Garifuna sample
from all other CAAPA sites (Supplementary Fig. 7). This
component reflects the unique history of the Garifuna (different
from other Hondurans described previously15), whose ancestors
originated from a single slave ship from West Africa that wrecked
on the West Indian island of St Vincent in the seventeenth
century16–18 with subsequent population bottlenecks as described
below.
Patterns of rare genetic variation in the CAAPA sequence data
recapitulate the complex population history of the Americas.
The series of bottlenecks unique to the Honduran Garifuna
population17–20 is evidenced by dramatically lower counts of total
singletons per individual in this sample (average¼ 15,946
compared with the other sampling sites ranging 26,545–35,565).
Consistent with other patterns of bottlenecks in this population,
we ran the IBDseq/IBDne pipeline using best practices
recommended by the authors21. We observe an elevation of
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Figure 1 | Whole-genome sequences of African-admixed populations in the Americas. (a) Geographical location of 16 CAAPA sites and estimates of
global ancestry across 642 samples from North, Central and South America and Africa. The transatlantic slave trade is illustrated for each colonial power,
along with beginning and end years of the transatlantic slave trade for British/North American, British, French and Spanish Caribbean, and Portuguese/
South America. The date of abolition of slavery noted for each country participating in the transatlantic slave trade. The bars depict the relative proportions
of African (blue), European (red) and Native American (green) contribution at each CAAPA site. (b) Percentage of SNVs within MAF categories
(1¼ singletons, 2¼MAFo1%, 3¼ 1%rMAFr5%, 4¼MAF45%) across all CAAPA sites illustrating discovery of novel variants (that is, those not
previously annotated in dbSNP) across all ranges of MAF. (c) Site-frequency spectrum of known and novel SNVs within CAAPA. (d) De-convolution of
novel alleles by ancestral background in CAAPA using a paired t-test illustrates an excess of novel alleles occurs on the African/African background in
contrast to the European/European and Native American/Native American background.
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median pairwise identity-by-descent (IBD) in the Garifuna
(167Mb), relative to an expected value of 0Mb for unrelated
individuals, as measured using the programme IBDseq across
the autosomes (Fig. 3a). Using this distribution of IBD
tracts, we could infer recent demographic history (via IBDNe22)
consistent with a severe bottleneck with recovery beginning 8
generations ago and a minimum effective population size
of 395 (95% confidence interval: 352–466; Fig. 3b). Comparing
this result with simulations derived from outbred European
populations, the observed pairwise IBD values are concordant
with the population being as related as second or third
cousins. This bottleneck is highly concordant with the historical
accounts of the population and helps to characterize the
founder effect-driven genetic patterns leading to PC3 in the
global data.
Patterns of derived doubleton sharing (capturing shared
ancestry at recent mutations) between populations also parallel
the proportion of African ancestry and historical records of the
slave trade. Specifically, Brazilians, Puerto Ricans, Colombians
and Dominicans (with estimated African ancestry ranging from
27 to 49% created by the Spanish–Portuguese slave trade) formed
one cluster, and Africans, Barbadians, Jamaicans and African
Americans (estimated African ancestry ranging from 76 to 99%
created by the British slave trade) formed another, with the
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Figure 2 | Genomic portraits of admixture heterogeneity within and between populations. (a) Estimates of global ancestry of the 642 individuals using
ADMIXTURE47 analysis on a set of 113,090 LD-pruned SNPs and 3 ancestral reference populations (CEU samples Utah from TGP to represent European
ancestry; YRI Yoruban samples from TGP to represent African ancestry; and Native American samples from Mao et al.46). (b) Principal component analysis
(EIGENSOFT48) using this same set of SNPs and ancestral reference populations illustrating the two main axes of genetic variation in all 642 samples.
(c) Heat map of doubleton sharing by population; colour is based on the percentiles of the number of doubletons per individual-pair from the same
population or from different populations. (d) Correlation between autosomal and X chromosome admixture estimates with the identity line in grey
(population membership defined as in b).
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unique Honduran Garifuna sharing very little with the other
groups (see Methods, Fig. 2c and Supplementary Fig. 8).
Deleterious variation in coding and non-coding regions.
Recent demographic events such as the African Diaspora have
clearly affected the frequency spectrum of SNVs in modern
populations8–11 but its impact on the average burden of
mutations carried by individuals remains more ambiguous.
Here we used an unbiased measure of conservation,
PhyloPNH23 to quantify evolutionary constraint and defined
deleterious variants as those with PhyloPNH scores exceeding
the 99.9th percentile of the empirical distribution of
conservation scores across the genome. At this cutoff, 4.2% of
all coding variants (including 6.2% of nonsense and 6.6% of
non-synonymous variants) and 0.06% of non-coding variants
were identified as putatively deleterious. On average, 1,625
deleterious SNVs were carried by each individual, ranging from
1,574 for Puerto Ricans to 1,645 for individuals from Barbados.
As expected24–26, individuals with more African ancestry carry
more predicted deleterious heterozygotes, but those with more
European ancestry carry more deleterious derived (compared
with the chimpanzee genome) homozygotes, probably a result
of the original Out-of-Africa migration (Fig. 4a). These
contrasting patterns of deleterious heterozygous and derived
homozygous genotypes effectively cancel each other; thus, the
average number of deleterious derived alleles per individual is
roughly the same with subtle differences as a function of
African ancestry (Spearman’s correlation between the number
of deleterious derived alleles per individual and the proportion
of African ancestry was r¼ 0.04, P¼ 0.36; Fig. 4a). These
patterns were robust to the metric selected for the definition of
‘deleterious’ and similar observations were confirmed when
Combined Annotation Dependent Depletion (CADD)27 scores
were used in conjunction with PhyloPNH (see Methods and Supple-
mentary Fig. 9A). Interestingly, the correlation between the number
of deleterious coding alleles per individual and global African
ancestry was negative r¼  0.23 (P¼ 5 10 9), whereas it was
positive r¼ 0.18 (P¼ 6 10 6) for deleterious non-coding sites
(Fig. 4b). These observations probably reflect differences in the
distribution of selective pressure acting on putatively deleterious
variants in protein-coding and non-coding regions, as reflected by
their PhyloPNH distributions (the median PhyloPNH scores were
3.006 and 2.976 for coding and non-coding deleterious sites,
respectively; Mann–Whitney test, P¼ 4 10 196; Fig. 4c). It is
important to note that we analysed cases and controls together here:
although this could potentially affect patterns of deleterious
variants, we assessed sensitivity by restricting the above analysis
to controls only (Supplementary Fig. 9B) and observed little
difference, both due to small overall genetic differences between
cases and controls, and due to the balance of cases and controls
across all sub-populations considered here (see Supplementary
Table 1).
This opposing correlation pattern remained when we
considered the heterogeneity of ancestry contributions across
the genome. For example, in each individual, we separately
considered sites whose two alleles could be unambiguously
inferred to come from the same ancestral population (that is,
African and European, respectively, via the local ancestry
estimation programme RFMix)28. We did not consider sites
inferred from Native American ancestry, because 78% of
individuals in CAAPA had Native American ancestry estimates
of o10%. Next, we compared the proportion of deleterious-
derived alleles per individual stratified by local ancestry. Among
coding sites, we saw proportionally fewer deleterious alleles in
regions of African ancestry compared with European ancestry
(that is, 1.33% and 1.41%, respectively; Mann–Whitney test,
P¼ 0.027). However, in non-coding sites the proportion of
deleterious alleles was 0.0294% for African ancestry and 0.0291%
for European ancestry (Mann–Whitney test, P¼ 6 10 5;
Supplementary Fig. 10), indicating a lower rate of deleterious-
derived alleles on segments of African background for coding
variants relative to non-coding ones. Thus, these results illustrate
how patterns of strongly and weakly deleterious SNVs vary
among populations and highlight how both population history
and natural selection can influence the burden of deleterious
variation and its impact on populations with recently mixed
ancestry.
Evidence for sex-biased gene flow. Historic accounts of mating
practices associated with the trans-Atlantic slave trade support
sex-biased gene flow in the peopling of the Americas and genetic
studies of African-admixed populations in North and South
America have shown a significantly higher European male
contribution. This process has been documented using
genetic data in the past15,29–33. Mating patterns during the
African Diaspora varied among colonial regions and we used
these CAAPA genomes to characterize differential sex-biased
admixture across the 16 CAAPA sites. Comparing estimated
admixture fractions of all CAAPA individuals between
all autosomes and the X chromosome (see Methods), we see
trends similar to previous studies15,29: female-biased contribution
of Native American ancestry (paired t-test; P¼ 1.2 10 12),
male-biased contribution of European ancestry (paired
t-test; P¼ 8.9 10 12) and a marginal overall female-biased
contribution of African ancestry (paired t-test; P¼ 0.055;
Supplementary Table 8, Fig. 2d and Supplementary Fig. 11).
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Figure 3 | High levels of identity by descent indicate a bottleneck unique
to the Honduran Garifuna population. (a) Density plot demonstrating
elevated pairwise IBD across the Garifuna sample summed across the
autosomes. Note: distribution filtered to remove first degree relatives
(b) Skyline plot of effective population size through time in the Garifuna,
as measured from pairwise IBD using the program IBDNe19. Line represents
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However, these omnibus statistics conflate two separate processes
of English and Spanish colonization. African Americans from
different US sites exhibited female-biased African and male-
biased European trends of admixture (Supplementary Table 8),
which agrees with their mitochondrial (maternally transmitted)
haplotypes being predominantly African (Supplementary
Table 9 and see Methods) and Y-chromosomal haplotypes
(paternally transmitted) being predominantly of European
origin (Supplementary Table 10 and see Methods). The pattern
observed in individuals from Barbados and Jamaica was similar to
African Americans, all of whom have a high proportion of
African ancestry (Supplementary Fig. 11). The Hondurans’
unique history relative to the other Latin American populations
is reflected in their higher proportion of African ancestry;
in addition, 16% of males carry the only Native American
Y-haplotypes seen among CAAPA Latin Americans
(Supplementary Fig. 11 and Supplementary Table 10).
Latin American individuals from Brazil, Colombia, the
Dominican Republic and Puerto Rico show admixture involving
Native American females and European males (Supplementary
Table 8 and Supplementary Fig. 11). These patterns of sex-biased
ancestry in CAAPA have the same trends as previous studies and
some differences may be due to sampling location: Barbadian,
Brazilian, Jamaican and Puerto Rican individuals in this study
were recruited in their country of origin (Supplementary Table 1)
rather than in the United States, which can have its own
ancestry-related biases. CAAPA Hondurans and Colombians
(from Cartagena, which was one of most active slave ports in
Latin America24) have a unique history and these specific sub-
groups have not previously been included in genetic studies34,35.
Although the impact of sex-bias in admixed populations of the
Americas has been well-established, including among some of the
populations included in CAAPA (that is, Brazilian, Colombian
and African American), to date to no study has examined sex-bias
in as large and diverse a data set as CAAPA (for example,
15 admixed populations across North, Central and South
America and the Caribbean). Moreover, there is utility in
understanding these processes among populations not recruited
in the United States, as has been done in the past, to avoid
potential immigration bias. Finally, the ubiquity of these
processes across admixed populations within and outside of the
United States is noteworthy. It will be of interest to expand these
studies, to quantify potentially different admixture processes in
Hispanic and non-Hispanic populations.
Discussion
Leveraging the largest current WGS catalogue of African-admixed
individuals from the Americas, we have demonstrated the
tremendous genetic variation resulting from the African
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Diaspora. Despite the large number of novel SNVs carried in
individuals of African descent, population history and natural
selection have combined to exert subtle impacts on heterozygosity
and the burden of deleterious variation. Patterns of genetic
distance and sharing of SNVs among these populations reflect the
unique population histories in each of the North, Central and
South American and Caribbean island destinations of West
African slaves, with their particular Western European colonials
and Native American populations.
A possible limitation in the study design of CAAPA for
examining the pattern of deleterious variants is the selection of
subjects on the basis of asthma status (as the long-term goal of
this project is to identify genetic determinants associated with risk
of asthma among populations of African ancestry). However, very
few significant differences were observed between asthmatics and
non-asthmatics in global admixture estimates by population
(Supplementary Table 1), and a sensitivity analysis restricted to
the non-asthmatics revealed no qualitative and only slight
quantitative differences in results (Supplementary Fig. 9B).
The complex demographic history present in all the popula-
tions in CAAPA can have a significant impact on the genome,
particularly in the number of rare variants10,11,36,37. How recent
events would influence the average burden of apparently
deleterious mutations, what proportion of these deleterious
mutations actually have true clinical relevance and whether the
proportion of deleterious alleles is higher in populations of
African ancestry remain unclear. These data underscore the
pitfalls of over-homogenizing African ancestry among African-
admixed individuals. Identifying a significant excess of novel
alleles on chromosomal regions of purely African ancestry
(compared with purely European or Native American
backgrounds) demonstrates the need for more exhaustive
sequencing studies in under-represented racial and ethnic
populations to fully catalogue the genetic architecture of disease
risk. This, combined with a significant decrease in linkage
disequilibrium in African populations38, is reflected in the
drastically lower coverage of African ancestry variants provided
by current commercial arrays of genome-wide markers (see
Methods, Supplementary Note 11, and Supplementary Figs 12
and 13). We anticipate the African Diaspora catalogue generated
from CAAPA will provide an important and unique reference
panel for designing the next generation of genotyping arrays,
which will capture a larger percentage of low frequency and rare
African variants than currently possible with commercial arrays,
providing a more appropriate resource for imputation.
We contend that this WGS data set from 642 individuals of
African ancestry representing 16 distinct geographical sites
(and peopling histories) is unique and constitutes a novel
resource for the scientific community. To this end, the African
Diaspora catalogue generated from CAAPA provides an impor-
tant and unique reference panel for designing the next generation
of genotyping arrays, which will capture a larger percentage of
low frequency and rare African variants than currently possible
with commercial arrays, provide a more appropriate resource for
imputation and ultimately facilitate gene discovery for traits in
individuals with African ancestry across the world. Major
initiatives underway, when combined with CAAPA, will greatly
expand the diversity, breadth and power of the African-ancestry
genome catalogue (that is, NIH NHLBI TopMed programme39,
H3Africa Consortium13, the Haplotype Reference Consortium40)
and ultimately facilitate gene discovery for traits in individuals
with African ancestry across the world.
Methods
Deleterious variant definition. Single-nucleotide polymorphism (SNP) annota-
tion was performed using the SeattleSeq Annotation server41; SNPs were annotated
as coding-notMod3, coding-synonymous, coding-synonymous-near-splice,
intergenic, intron, missense, missense-near-splice, near-gene-3, near-gene-5,
splice-3, splice-5, stop-gained, stop-gained-near-splice, stop-loss, utr-3, utr-5 and
coding-notMod3-near-splice. We annotated allele ancestry state based on the six
primate Endero, Pecan, Ortheus (EPO) alignments and filtered out sites whose
ancestral inference had low confidence (that is, ancestral state only supported by
one sequence based on the six primate EPO alignments)8. Finally, 38,424,038 SNVs
were included in the analysis.
Quantification of evolutionary constraints via sequence conservation was widely
used to characterize deleterious variants that may have been subject to purifying
selection. However, when calculating conservation score when the considering the
human reference genome (for example, PhyloP with the human reference genome,
PhyloPH), a strong bias was observed, as most SNVs where the human genome
reference carries the derived allele tend to be classified as ‘benign’, regardless of the
population frequency42–44. To correct this bias, we applied PhyloPNH (PhyloP
without the human reference genome) to measure the conservation of genetic sites
as previously performed44. Briefly, PhyloPNH was based on multiple alignments of
EPO 36 eutherian mammal genomes downloaded from Ensembl genome browser
and excluding the human reference genome. We defined deleterious variants as
those exceeding the 99.9th percentile of PhyloPNH (that is, Z2.907).
To explore the robustness of our results to our definition of a deleterious
variant, we also applied a filter based on CADD score27. In this setting, to declare a
variant deleterious, we required both PhyloPNHZ2.907 and either a CADD cutoff
of 30 (corresponding to 99.9th percentile of the genome, in terms of
deleteriousness) or a cutoff of 20 (99th percentile of genome).
PolyPhen2 scores for missense variants. SeattleSeq annotations were used to
classify synonymous and non-synonymous SNPs and obtain further functional
predictions for each missense variant identified from PolyPhen2 (ref. 45; that is,
Probably Damaging, Possibly Damaging and Benign). There have been previous
studies documenting strong reference bias existing at sites where the genome
reference allele is a derived allele, which results in functional prediction
programmes designating a high proportion of these sites as being likely to be
non-functional or benign, even when the reference allele is rare in the population
overall42. To minimize this bias, we filtered out functional designations at sites
where the reference allele was derived as unreliable, similar to approaches adopted
by Simons et al.42 To explore robustness of our results to our choice of PolyPhen2,
we applied an alternative filter, which combined the PolyPhen2 ‘probably
damaging’ designation with a SIFT score46 cutoff of r0.05.
Rarefaction curves to predict abundance of variation yet to be discovered. As
most of the observed variation in CAAPA was novel and rare, we asked whether
there are more SNVs to discover as our sample size would increase, or whether the
rate of SNP discovery had actually plateaued. Under the standard neutral model of
molecular evolution, the number of SNVs discovered is proportional to the partial
harmonic series12. This function grows logarithmically; thus, it is expected returns
would be quite diminished after sequencing B500 individuals. In contrast, the
non-equilibrium demographic history of modern humans places most populations
well off of this curve. We demonstrate this effect using rarefaction curves, which
show the fraction of SNVs discovered as a function of sample size across multiple
annotations (including the standard neutral model). We then used jackknife
projections12 to extrapolate the rate of SNV discovery into larger sample sizes, to
determine the extent of SNV discovery that would be possible with a larger sample.
Reference populations used for estimates of admixture. We implemented
protocols similar to those established for the TGP reference populations13
including the same set of 85 Utah residents with Northern and Western European
ancestry (CEU), 88 Yoruba samples from Ibadan, Nigeria (YRI) and 43 Native
Americans. The Native Americans were selected from Mao et al.47 with 99% or
higher Native American ancestry estimated by ADMIXTURE48. Subsequent
to merging the data between CAAPA and these ancestral populations, we
obtained a total of 551,510 autosomal SNPs available for analysis; SNPs with45%
missingness were dropped for this final set of merged data. For methods
described below that require a set of linkage diseqilibrium-pruned SNPs, we
removed SNPs with an R2-value40.1 within every 50 SNP window (sliding by
10 SNPs as recommended for ADMIXTURE) and also removed ambiguous SNPs
whose strand orientation could not be determined (that is, G/C and A/T SNPs).
This yielded a total of 113,090 linkage disequilibrium (LD)-pruned SNPs. Global
estimates of admixture were obtained for all 643 independent samples subsequent
to the IBD analysis performed above using ADMIXTURE48 and including the 3
reference populations. An initial unsupervised analysis was performed with
K¼ 1–5, to determine the optimal number of ancestral reference groups needed.
Setting K¼ 3 gave the lowest cross-validation error and this was selected as the
K under which the final analysis was performed to generate global estimates of
ancestry for each sample (Supplementary Fig. 5). We found one African American
sample with an estimated African ancestry of 0.001%, that is, essentially no
detectable African ancestry, and this sample was dropped from further analysis
given its high likelihood of error in DNA plating. The final set of independent
samples used in all subsequent analysis was N¼ 642.
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Principal component analysis. We used EIGENSOFT49 to perform PCA analysis
and the R package was used to generate graphical overviews of these results
(Supplementary Figs 6 and 7). Primary analysis was performed including all 642
CAAPA subjects and reference populations from 85 CEU, 88 YRI and 43 Native
Americans described above. Analysis was also performed on a subset of 328
African Americans and 205 samples from all populations with 45% Native
American component within CAAPA, each with the same reference populations.
PCA analyses were performed using the set of LD-pruned 113,090 SNPs described
above.
Ancestry estimates by site. We used RFMix28 (v1.0.2) to generate local ancestry
probabilities from Affymetrix Genome-Wide Human SNP Array 6.0 on CAAPA
samples, as well as 85 CEU, 88 YRI and 43 Native Americans from the TGP. The
set of 551,510 autosomal SNPs available for analysis in the combined data set were
used in the estimation of local ancestry; SNPs with 45% missingness in the
combined data set were dropped in this final set of merged data. Data were suitably
formatted for BEAGLE50, which was used to phase the data for each population in
each chromosome. We then used R code to convert BEAGLE output to RFMix
format. RFMix was run using Python 2.7 and the Forward–Backward output
calculating the posterior probability of each ancestry at each SNP per haplotype.
We then used R code to assign ancestral categories from the Forward–Backward
output onto the multi-sample vcf file for both alleles at each site per chromosome.
Ancestral codes were assigned using the TGP protocol51 with 0¼ unknown,
1¼ European:European, 2¼ European:African, 3¼African:African,
4¼ European:Native American, 5¼African:Native American and 6¼Native
American:Native American.
Doubleton analysis. In total, we observed 3,763,898 derived doubletons with
missingness r5% for which we observed exactly two copies of derived alleles in
642 individuals. We counted the number of doubletons shared by each individual
pair. According to the populations/sampling sites the individual pair belonged to,
we normalized the number by the total possible number of individual pairs and
summed over all pairs. We generated heat maps using R to exhibit the pattern of
doubleton sharing across populations, sampling sites or individuals
(Supplementary Fig. 8).
X-chromosomal admixture analysis. To compare admixture estimates from
autosomes and the X chromosome35,52,53, analysis was restricted to only
females (to ensure we compared a diploid X to diploid autosomes). We ran
ADMIXTURE48 at K¼ 3 on the X chromosome and autosomes separately as
described in Methods (for example, 113,090 LD-pruned SNPs were used for the
autosomes and 3,611 LD-pruned SNPs were used for the X chromosome). Mothers
transmit an X chromosome to all their children, whereas fathers transmit an X
chromosome only to their daughters. Although gender in contemporary
individuals has negligible impacts on the long-term evolutionary view, there can be
a marked difference in the contribution of ancestral groups. Thus, if females from a
specific ancestral population contributed more to current admixed population
(that is, female-biased admixture), the admixture fraction estimated from X
chromosome SNVs should be larger than seen for SNVs from autosomes for this
ancestral population. In contrast, if males from a specific ancestral population
contributed more to the admixed population (that is, male-biased admixture), the
admixture fraction for SNVs on the X should be smaller than that in autosomes for
this ancestral population. To determine sex-biased admixture in the admixed
populations, we tested for equality of the ancestral African, European and Native
American proportions between the X chromosomes and the autosomes using a
paired t-test to account for unequal sample variances. As the estimated ancestry
proportions are constrained to sum to 1 for each individual for each type of SNV
(autosomal or X-chromosomal) and the ancestry estimates for populations are
correlated due to their admixture histories, we corrected P-values for 57 multiple
tests using a conservative Bonferroni correction.
Mitochondrial haplotypes. To classify mitochondrial haplotypes into
haplogroups for the 642 CAAPA males and females, we analysed mitochondrial
variant calls with the programme HaploGrep54, following phylotree build 16
topology55. For sites with low-confidence calls, we manually reviewed haplotypes to
confirm haplogroup classifications according to phylotree build 16 (http://
www.phylotree.org). Based on mitochondrial DNA phylogeography, individuals
from Jamaica, Nigeria and Barbados have almost exclusively sub-Saharan African
mitochondrial lineages. Of the 328 African American individuals, 297 (90.5%) have
a sub-Saharan African maternal origin based on their mtDNA lineages, 18 (5.5%)
have a European origin and 13 (4.0%) have some other origins (Native American,
Asian or North African). Of the 205 remaining individuals from Brazil, Colombia,
Dominican Republic, Honduras and Puerto Rico, 106 (51.7%) have an sub-Saharan
African origin, 80 (39.0%) have Native American lineages and 19 (9.3%) have a
European or some other geographical assignations. There are two B4a1a1 and three
novel E1a1a sub-lineages present in the sample that might be associated with the
Malagasy slave trade and indicates a diverse history of CAAPA individuals56.
The full list of haplotypes is in Supplementary Data 1.
Y-chromosomal haplotypes. Y chromosomal haplotypes of CAAPA males in
Supplementary Table 10 were determined using a pipeline from Poznik et al.57 and
Haplogrep54, and have the following geographical distribution. The B1, B2, E1a
and E2 haplotypes are African; E1b haplotypes are most likely to be of African
origin given the sampling locations; G, I and J haplotypes are most likely to be
European; Q1a is Native American; R1a is Asian; and of the 76 R1b haplotypes,
74 are European and 2 are African58. It is notable that three of the four observed
Q1a Native American haplotypes are in Hondurans. Nigerians carry exclusively
African haplotypes. In African Americans, 59.8% of the haplotypes are African
E1b, 20.6% are European R1b and 19.6% are other types that are mostly European.
The remaining groups have the following composition of non-European
haplotypes. Honduras: 78.9% African, 15.7% Native American; Barbados: 81.8%
African; Brazil: 20% African; Colombia: 12.5% African; Dominican Republic: 36.8%
African; Jamaica: 60.8% African; and Puerto Rico: 12.5% African.
Data availability. The WGS data that support the findings of this study have been
deposited in dbGAP with the accession code phs001123.v1.p1. All relevant data can
be accessed through dbGAP. Specific data use limitations: GRU-IRB (General
Research Use, IRB approval required).
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